Minimizing cost associated with management of heparin-induced thrombocytopenia: A cost analysis of various laboratory testing models.
Autorzy:
Northam KA; Department of Pharmacy, University of North Carolina Medical Center, Chapel Hill, NC, USA. Johnson JA; Eshelman School of Pharmacy, University of North Carolina, Chapel Hill, NC, USA. Behrens A; Department of Pharmacy, University of North Carolina Medical Center, Chapel Hill, NC, USA. Chen SL; Department of Pharmacy, University of North Carolina Medical Center, Chapel Hill, NC, USA. KasthuriRS; Division of Hematology, University of North Carolina, Chapel Hill, NC, USA. Rollins-Raval M; Department of Pathology, University of New Mexico, Albuquerque, NM, USA.
Emicizumab reduces re-hospitalization for bleeding in acquired haemophilia A.
Autorzy:
Chen SL; Department of Pharmacy, University of North Carolina Medical Center, Chapel Hill, North Carolina, USA. Ellsworth P; Department of Medicine, Division of Hematology and Blood Research Center, University of North Carolina at Chapel Hill, Chapel Hill, North Carolina, USA. KasthuriRS; Department of Medicine, Division of Hematology and Blood Research Center, University of North Carolina at Chapel Hill, Chapel Hill, North Carolina, USA. Moll S; Department of Medicine, Division of Hematology and Blood Research Center, University of North Carolina at Chapel Hill, Chapel Hill, North Carolina, USA. Ma AD; Department of Medicine, Division of Hematology and Blood Research Center, University of North Carolina at Chapel Hill, Chapel Hill, North Carolina, USA. Key NS; Department of Medicine, Division of Hematology and Blood Research Center, University of North Carolina at Chapel Hill, Chapel Hill, North Carolina, USA.
Impact of a multidisciplinary workflow on safety and management of patients with heparin-induced thrombocytopenia.
Autorzy:
Northam KA; Department of Pharmacy, University of North Carolina Medical Center, Chapel Hill, NC. Chen SL; Department of Pharmacy, University of North Carolina Medical Center, Chapel Hill, NC. Stivers AP; Department of Pharmacy, Emory University Hospital Midtown, Atlanta, GA. Cicci JD; Department of Pharmacy, University of North Carolina Medical Center, Chapel Hill, NC. Hedrick TL; Department of Pharmacy, University of North Carolina Medical Center, Chapel Hill, NC. Rollins-Raval MA; Department of Pathology, University of New Mexico, Albuquerque, NM. KasthuriRS; Division of Hematology and Oncology, University of North Carolina, Chapel Hill, NC.
Secondary Immune Thrombocytopenia in Metastatic Renal Cell Carcinoma: A Case Report and Discussion of the Literature.
Autorzy:
Cockrell DC; Department of Medicine, University of North Carolina School of Medicine, Chapel Hill, North Carolina, USA. KasthuriRS; Department of Medicine, University of North Carolina School of Medicine, Chapel Hill, North Carolina, USA.; Blood Research Center, University of North Carolina, Chapel Hill, North Carolina, USA.; Lineberger Comprehensive Cancer Center, University of North Carolina, Chapel Hill, North Carolina, USA. Altun E; Division of Abdominal Imaging, Department of Radiology, University of North Carolina School of Medicine, Chapel Hill, North Carolina, USA. Rose TL; Department of Medicine, University of North Carolina School of Medicine, Chapel Hill, North Carolina, USA.; Lineberger Comprehensive Cancer Center, University of North Carolina, Chapel Hill, North Carolina, USA. Milowsky MI; Department of Medicine, University of North Carolina School of Medicine, Chapel Hill, North Carolina, USA.; Lineberger Comprehensive Cancer Center, University of North Carolina, Chapel Hill, North Carolina, USA.
Pokaż więcej
Źródło:
Case reports in oncology [Case Rep Oncol] 2020 Nov 25; Vol. 13 (3), pp. 1349-1356. Date of Electronic Publication: 2020 Nov 25 (Print Publication: 2020).
Integration of clinical parameters, genotype and epistaxis severity score to guide treatment for hereditary hemorrhagic telangiectasia associated bleeding.
Autorzy:
Beckman JD; Department of Medicine, Division of Hematology, Oncology, and Transplantation, University of Minnesota, Minneapolis, MN, 55455, USA. Li Q; Department of Biostatistics, University of North Carolina at Chapel Hill, Chapel Hill, NC, USA. Hester ST; Department of Internal Medicine, University of North Carolina at Chapel Hill, Chapel Hill, NC, USA. Leitner O; Department of Genetics, University of North Carolina at Chapel Hill, Chapel Hill, NC, USA. Smith KL; Department of Medicine, Division of Hematology/Oncology, University of North Carolina at Chapel Hill, CB#7035, 8206B Mary Ellen Jones Bldg, 116 Manning Drive, Chapel Hill, NC, 27599, USA. KasthuriRS; Department of Medicine, Division of Hematology/Oncology, University of North Carolina at Chapel Hill, CB#7035, 8206B Mary Ellen Jones Bldg, 116 Manning Drive, Chapel Hill, NC, 27599, USA. raj_kasthuri@med.unc.edu.
Pokaż więcej
Źródło:
Orphanet journal of rare diseases [Orphanet J Rare Dis] 2020 Jul 13; Vol. 15 (1), pp. 185. Date of Electronic Publication: 2020 Jul 13.
Typ publikacji:
Journal Article; Research Support, N.I.H., Extramural; Research Support, Non-U.S. Gov't
Challenges in diagnosis and management of acquired factor XIII (FXIII) inhibitors.
Autorzy:
Beckman JD; Division of Hematology/Oncology, Department of Medicine, University of North Carolina at Chapel Hill, Chapel Hill, North Carolina. KasthuriRS; Division of Hematology/Oncology, Department of Medicine, University of North Carolina at Chapel Hill, Chapel Hill, North Carolina. Wolberg AS; Department of Pathology and Laboratory Medicine, University of North Carolina at Chapel Hill, Chapel Hill, North Carolina. Ma AD; Division of Hematology/Oncology, Department of Medicine, University of North Carolina at Chapel Hill, Chapel Hill, North Carolina.
Management of adult non-severe haemophilia A patients with inhibitors: a practice-pattern survey.
Autorzy:
Lim MY; Division of Hematology/Oncology, Department of Medicine, University of North Carolina, Chapel Hill, NC, USA. Buckner TW; Division of Hematology, Department of Medicine, University of Colorado School of Medicine, Aurora, CO, USA. KasthuriRS; Division of Hematology/Oncology, Department of Medicine, University of North Carolina, Chapel Hill, NC, USA.; UNC Hemophilia and Thrombosis Center, Chapel Hill, NC, USA. Ma AD; Division of Hematology/Oncology, Department of Medicine, University of North Carolina, Chapel Hill, NC, USA.; UNC Hemophilia and Thrombosis Center, Chapel Hill, NC, USA. Key NS; Division of Hematology/Oncology, Department of Medicine, University of North Carolina, Chapel Hill, NC, USA.; UNC Hemophilia and Thrombosis Center, Chapel Hill, NC, USA.
RBC barcoding allows for the study of erythrocyte population dynamics and P. falciparum merozoite invasion.
Autorzy:
Clark MA; Department of Microbiology & Immunology, University of North Carolina at Chapel Hill, Chapel Hill, North Carolina, United States of America. Goheen MM; Department of Microbiology & Immunology, University of North Carolina at Chapel Hill, Chapel Hill, North Carolina, United States of America. Spidale NA; Department of Microbiology & Immunology, University of North Carolina at Chapel Hill, Chapel Hill, North Carolina, United States of America. KasthuriRS; Division of Hematology, University of North Carolina at Chapel Hill, Chapel Hill, North Carolina, United States of America. Fulford A; Department of Epidemiology, University of North Carolina at Chapel Hill, Chapel Hill, North Carolina, United States of America. Cerami C; Medical Research Council International Nutrition Group, London School of Hygiene and Tropical Medicine, London, United Kingdom & Medical Research Council Keneba, The Gambia.
Pokaż więcej
Źródło:
PloS one [PLoS One] 2014 Jul 01; Vol. 9 (7), pp. e101041. Date of Electronic Publication: 2014 Jul 01 (Print Publication: 2014).
Typ publikacji:
Journal Article; Research Support, N.I.H., Extramural; Research Support, Non-U.S. Gov't
Ta witryna wykorzystuje pliki cookies do przechowywania informacji na Twoim komputerze. Pliki cookies stosujemy w celu świadczenia usług na najwyższym poziomie, w tym w sposób dostosowany do indywidualnych potrzeb. Korzystanie z witryny bez zmiany ustawień dotyczących cookies oznacza, że będą one zamieszczane w Twoim komputerze. W każdym momencie możesz dokonać zmiany ustawień dotyczących cookies
